Jodie A. Schildkraut

Author

Also Known As

J. A. Schildkraut, Jodie A Schildkraut, Jodie A. Schildkraut, Jodie Anne Schildkraut, Jodie Schildkraut, Schildkraut, Jodie A.

Publications

452

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen London School of Hygiene & Tropical Medicine Addis Ababa University Armauer Hansen Research Institute

About

Jodie A. Schildkraut is an author at Radboud University Medical Center specializing in pulmonary disease, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	44
2	Public Health	1	1	44
3	Epidemiology	1	1	44
4	Pulmonary Disease	1	1	44
5	Clinical Epidemiology	1	1	44

Jodie A. Schildkraut

Publications

340

Citations

H-Index

Page 1

	Year	Citations
The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia Fitsum G. Tadesse, Lotus L. van den Hoogen, Kjerstin Lanke, Malaria Journal	2017	73
Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial Fitsum G. Tadesse, Kjerstin Lanke, Issa Nébié, American Journal of Tropical Medicine and Hygiene	2017	58
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation Jodie A. Schildkraut, Jack R. Gallagher, Kozo Morimoto, Respiratory Medicine EpidemiologyAdvanced Lung DiseaseClinical EpidemiologyRespiratory InfectionInfectious Respiratory Disease	2020	44
The role of amikacin in the treatment of nontuberculous mycobacterial disease J. A. M. Raaijmakers, Jodie A. Schildkraut, Wouter Hoefsloot, Expert Opinion on Pharmacotherapy	2021	33
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps Saskia E Mudde, Jodie A. Schildkraut, Nicole C. Ammerman, Journal of Global Antimicrobial Resistance	2022	32
The role of rifampicin within the treatment of <i>Mycobacterium avium</i> pulmonary disease Jodie A. Schildkraut, J. A. M. Raaijmakers, Rob E. Aarnoutse, Antimicrobial Agents and Chemotherapy	2023	25
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands Jodie A. Schildkraut, Sanne M.H. Zweijpfenning, Martijn Nap, ERJ Open Research	2021	21
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease Mike Marvin Ruth, Jasper Sangen, Lian J. Pennings, Antimicrobial Agents and Chemotherapy	2018	18
Thioridazine Is an Efflux Pump Inhibitor in Mycobacterium avium Complex but of Limited Clinical Relevance Mike Marvin Ruth, Lian J. Pennings, Valerie A. C. M. Koeken, Antimicrobial Agents and Chemotherapy	2020	15
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial Norbert Heinrich, Christina Manyama, Simon E. Koele, The Lancet Infectious Diseases	2025	11

Page 1